Epstein barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications

Journal of Neuropathology and Experimental Neurology

Volumn 67, Issue 11, 2008, Pages 1103-1111

  Kleinschmidt DeMasters, B K ^a   Damek, Denise M ^a   Lillehei, Kevin O ^a   Dogan, Ahmed ^b   Giannini, Caterina ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b Department of Hematology ^*  (United States)

^c MAYO CLINIC   (United States)

Author keywords

Azathioprine; Cell cept; Epstein barr virus; Immunocompetent; Immunocompromised; Malignant melanoma; Mycophenolate mofetil; Prednisone; Primary lymphoma

Indexed keywords

AZATHIOPRINE; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GABAPENTIN; GANCICLOVIR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; STEROID; CD3 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

AGED; ARTICLE; ATAXIA; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; BONE LESION; BONE PAIN; BRAIN DAMAGE; BRAIN EDEMA; CASE REPORT; COLON BIOPSY; CORONARY ARTERY DISEASE; CRANIOTOMY; CYTOMEGALOVIRUS INFECTION; DEFENSE MECHANISM; DISEASE ASSOCIATION; DISEASE DURATION; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG WITHDRAWAL; ENTEROPATHY; EPSTEIN BARR VIRUS; FEMALE; GERIATRIC PATIENT; HEADACHE; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; INTERSTITIAL PNEUMONIA; KIDNEY FAILURE; LUNG FIBROSIS; LUNG GRANULOMA; MALE; MELANOMA; MEMBRANOUS GLOMERULONEPHRITIS; MULTIPLE CYCLE TREATMENT; MULTIPLE ORGAN FAILURE; MYASTHENIA GRAVIS; NEPHROTIC SYNDROME; NEUROIMAGING; NEUROPATHOLOGY; PANCYTOPENIA; PHYSIOTHERAPY; POLYMYOSITIS; POLYNEUROPATHY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RHEUMATOID ARTHRITIS; THROMBOPHLEBITIS; THYMECTOMY; TREATMENT DURATION; VASCULAR DISEASE; VIRUS LOAD; CENTRAL NERVOUS SYSTEM TUMOR; GENERAL APPARATUS, EQUIPMENT AND SUPPLIES; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOMA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS INFECTION;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTIGENS, CD3; CENTRAL NERVOUS SYSTEM NEOPLASMS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA; MALE; METHOTREXATE; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 58149263539     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31818beaea     Document Type: Article

References (27)

1. Nuckols JD, Liu K, Burchette JL, et al. Primary central nervous system lymphomas: A 30-year experience at a single institution. Mod Pathol 1999;12:1167-73
2. Batara JF, Grossman SA. Primary central nervous system lymphomas. Curr Opin Neurol 2003;16:671-75
3. Corn BW, Marcus SM, Topham A, et al. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 1997;79:2409-13
4. Kadan-Lottick NS, Skluzacek MC, Gurney JG. Decreasing incidence rates of primary central nervous system lymphoma. Cancer 2002;95: 193-202
5. Remick SC, Diamond C, Migliozzi JA, et al. Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature. Medicine 1990;69:345-60
6. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1993;119:1093-1104
7. Bower M, Powles T, Nelson M, et al. Highly active antiretroviral therapy and human immuno-deficiency virusYassociated primary cerebral lymphoma. J Natl Cancer Inst 2006;98:1088-91
8. Bashir R, McManus B, Cunningham C, et al. Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompro-mised patients. J Neurooncol 1994;20:47-53
9. Mullen JT, Vartanian TK, Atkins MB. Melanoma complicating treatment with natalizumab for multiple sclerosis. N Engl J Med 2008;358: 647-48
10. Polman CH, O'Connor placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006;354:899-910
11. Theriault C, Galoin S, Valmary S, et al. PCR analysis of immunoglob-ulin heavy chain (IgH) and TcR-F chain gene rearrangements in the diagnosis of lymphoproliferative disorders: Results of a study of 525 cases. Mod Pathol 2000;13:1269-79
12. Kleinschmidt-DeMasters BK, Gilden DH. The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol 2001;11: 440-51
13. O'Neill BP, Vernino S, Dogan A, et al. EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil. Neurooncology 2007;9:364-69
14. Vernino S, Salamao DR, Habermann TM, et al. Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil. Neurology 2005;65:639-41
15. Finelli PF, Naik K, DiGuiseppe JA, et al. Primary lymphoma of CNS, mycophenolate mofetil and lupus. Lupus 2006;15:886-88
16. Dasgupta N, Gelber AC, Racke F, et al. Central nervous system lymphoma associated with mycophenolate mofetil in lupus nephritis. Lupus 2005;14:910-13
17. Edge JC, Outland JD, Dempsey JR, et al. Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. Arch Dermatol 2006;142:65-69
18. Waldman MA, Callen JP. Self-resolution of Epstein-Barr virusY associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate. J Am Acad Dermatol 2004;51:S124-30
19. Herrlinger U, Weller M, Dichgans J, Melms A. Association of primary central nervous system lymphoma with long-term azathioprine therapy for myasthenia gravis? Ann Neurol 2000;47:682-83
20. Grulich AE, vanLeeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007;370:59-67
21. Laing ME, Moloney FJ, Kay EW, et al. Malignant melanom1a in transplant patients: A review of five cases. Clin Exp Dermatol 2006;31: 662-64
22. Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon Beta-1a for multiple sclerosis. N Engl J Med 2005;353:369-74
23. Langer-Gould A, Atlas SW, Green AJ, et al. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005;353:375-81
24. VanAssche G, VanRanst M, Sciot R, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005;353:362-68
25. Schwindt H, Akasaka T, Zühlke-Jenisch R, et al. Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and may be association with aberrant somatic hypermutation or defective class switch recombination. J Neuropathol Exp Neurol 2006;65:776-82
26. Rao CR, Jain K, Bhatia K, et al. Association of primary central nervous system lymphomas with the Epstein-Barr virus. Neurol India 2003:51: 237-40
27. Larocca LM, Capello D, Rinelli A, et al. The molecular and phonotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 1998;92:1011-19